In April 2010, Dr. Matsumura and his colleagues at the ALIN Foundation announced an historic achievement: all cancer patients treated with the SEF Chemo® in 2006 not only went into remission, but remained cancer-free without the toxic side effects normally associated with chemotherapy. The results on patients undergoing SEF Chemo® are nothing short of stunning. One [...]
About Dr. MatsumuraThis author has not yet filled in any details.
So far Dr. Matsumura has created 6 blog entries.
Breast cancer is a serious topic, and has been a major concern worldwide for hundreds of years. For over 50 years doctors have recommended women get mammograms, an easy to preform non-intrusive screening method for early detection. Because breast cancer is more common in women over 40, younger women are not advised to receive [...]
Radiotherapy in Early Breast Cancer: Pros & Cons by Amanda Remington, Information Resource Specialist The Berkeley Institute for Advanced Cancer Therapy Radiation therapy is often times the recommended treatment for early breast cancer once surgery is complete. Radiation is used to help eliminate cancer cells that may have been left behind after surgery. If [...]
8-Week SEF Chemotherapy® to Take Place of 6-9 Month "Adjuvant" Chemo-radiotherapy Published data from the United States National Cancer Institute show that more than half of stage III breast cancer patients eventually succumb despite undergoing six months of grueling toxic adjuvant chemo-radiotherapy after a lumpectomy. The reason is that conventional chemotherapy is inadequate and fails to [...]
SEF Chemo® Therapy Explained For generations, a definitive cure for cancer has been just out of reach. Researchers and clinicians know that existing drugs could be used to cure cancer if only they were not so toxic to normal tissues. It is impossible to administer cancer medications in doses high enough to eradicate every [...]
How SEF Chemo was Developed: My Personal Story By Dr. Ken Matsumura Today, large pharmaceutical companies have created a regulatory and marketing environment in which only billion dollar companies can hope to bring out a breakthrough medicine. The story of how SEF Chemo® was developed outside this environment by a small but innovative Berkeley foundation [...]